Today on Outsourcing-Pharma.com   Rumours of Pfizer, Sanofi mega-merger emerge Parexel purchases Taiwan firm Dr Reddy's beefs up quality image 'We are not anti-Asia' says EU chemicals body US firm unveils new cell culture services

Related Industry News   FDA backs tablet imaging tech Granulation technology launched Three more nailed in fake drugs scandal Investors jump into PDL stock in hope of imminent buyout

Breaking News on Outsourcing Pharma
Daily  Tuesday 09 October 2007		Forward to a colleague

	Sponsored Link Introducing Catalent Pharma Solutions Catalent Pharma Solutions is the leading provider of advanced technologies as well as development, manufacturing and packaging services for pharmaceutical, biotechnology and consumer health companies in nearly 100 countries... Click Here Access Full Stories Rumours of Pfizer, Sanofi mega-merger emerge Rumours that Pfizer is looking into buying a large stake in Sanofi-Aventis, which could be seen as a prelude to a full takeover bid, has prompted a flurry of shareholder activity... Read Parexel purchases Taiwan firm Parexel has purchased a clinical research organisation (CRO) in Taiwan as a means to exert its presence in this industry's budding Asia-Pacific region... Read Dr Reddy's beefs up quality image India's Dr Reddy's Laboratories has become the first company in the world to receive a new verification mark for two of its products, it was announced last week at the CPhI trade show in Milan... Read 'We are not anti-Asia' says EU chemicals body There have been more calls this month to tighten regulations on pharmaceutical ingredient suppliers in the wake of the recent safety concerns emanating from low-cost regions such as China and India.  However,... Read US firm unveils new cell culture services US drug discovery firm BioProcessors has unveiled a new range of cell culture services to assist in biopharmaceutical process development... Read
	All News Headlines for: October | September | August
	Product Brochure Baxter's contract services case study Baxter's contract services case study details the expedited transfer of a commercial launched lyophilized drug to a new production site. Their team designed solutions resulting in cost savings, yield improvement and cycle optimization... Click Here
	Related Industry News FDA backs tablet imaging tech UK-based TeraView has had its tablet imaging technology backed by the US Food and Drug Administration (FDA), following a study by the regulatory agency... Read Granulation technology launched Finland-based Atacama Labs has launched its proprietary technology system for developing solid oral dosage forms... Read Three more nailed in fake drugs scandal Three more individuals have been sentenced following last month's exposure of the largest counterfeit drugs conspiracy ever to be encountered in the UK... Read Investors jump into PDL stock in hope of imminent buyout Furious trading in shares of PDL BioPharma has taken place over the past couple of days as investors jumped in with both pockets open in the hope that a partner will soon be in the offing for the ailing firm... Read Weekly Comment FDA told its safety monitoring of clinical trials not good enough The US Food and Drug Administration (FDA) has been called into question again after the release of a damning report, this time suggesting the agency is inadequate in its safety monitoring of clinical trials. Read Previous Headlines CPhI show: news in brief Pharmaceutical manufacturers were in full force at this year's CPhI trade show held in Milan, where several new company announcements were made... Read Pharmaceuticals is top R&D spender As an increasingly desperate pharma industry strives to fill drug pipelines, the sector has, for the first time, topped a poll of which industries spend the most on research and development... Read UK innovation to get billion pound boost The UK government has set-aside £1bn (€1.45bn) to give early-stage companies better support after a review of the UK's science and innovation policies by Lord Sainsbury of Turville... Read Excipients unregulated and unacceptable The European Fine Chemicals Group (EFCG) has called for stricter regulation of pharmaceutical excipients in a bid to prevent substandard and potentially dangerous products ending up in medicinal drugs... Read Clinical staffing a 'tremendous problem' The European clinical trials industry is experiencing a "tremendous problem" with staff recruitment - salaries are climbing as a result... Read Product Innovation Alerts - Free of Charge Indicate your research interests and receive alerts on relevant products and market innovations Analytical testing, QC Bulk ingredients Contract sales & marketing Data management Drug delivery, formulation Fill & finish, packaging Phase I-II Phase III-IV Preclinical Product & Supplier News - Contract Manufacturing Regulatory affairs Supply chain, logistics Validation services

	Free Newsletters for Pharmaceuticals Access now !Choose from over 20 industry e-newsletters Access Decision News Media e-newsletters for the food, beverage & nutrition industries, click here
	Forward to a colleague

	To continue to receive this newsletter in your inbox, please add newsletter@OutSourcing-Pharma.com to your address book
	Update preferences | Change your email address | Unsubscribe
	Contact us: Advertising | Recruitment | Privacy policy | Terms & conditions | Feedback
	© 2007 - Decision News Media S.A.S - All Rights Reserved Le Belem - 355, rue Vendemiaire - 34000 Montpellier - France http://www.decisionnewsmedia.com